<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe acquired antithrombin III (AT III) deficiency was observed in a patient with <z:e sem="disease" ids="C0341950" disease_type="Disease or Syndrome" abbrv="">severe pre-eclamptic toxaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma AT III concentration of 0.25 U/ml was found in both functional and immunological assays </plain></SENT>
<SENT sid="2" pm="."><plain>The patient was treated with human AT III concentrate as a result of the development of progressive <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> (<z:chebi fb="0" ids="53092">DIC</z:chebi>), the further deterioration of renal function, the risk for thromboembolic complications and the possible adverse effects of <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy </plain></SENT>
<SENT sid="3" pm="."><plain>The selective correction of AT III activity resulted in a rapid disappearance of <z:hpo ids='HP_0001928'>coagulation abnormalities</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The patient underwent uncomplicated <z:hpo ids='HP_0011410'>caesarian section</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>This observation indicates that acquired severe AT III deficiency may occur as an early feature of <z:chebi fb="0" ids="53092">DIC</z:chebi> in <z:e sem="disease" ids="C0341950" disease_type="Disease or Syndrome" abbrv="">severe pre-eclamptic toxaemia</z:e> </plain></SENT>
</text></document>